These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31782000)

  • 1. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
    Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential].
    Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA
    Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
    Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
    Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
    Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Marker System for Early Diagnosis of Breast Cancer.
    Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hyper-methylated genes microRNA as potential markers of clear-cell carcinoma of kidney].
    Beresneva EV; Loginov VI; Khodyrev DS; Pronina IV; Kazubskaya TP; Karpukhin AV; Braga EA; Kushlinskii NE
    Klin Lab Diagn; 2017 Jan; 62(1):13-8. PubMed ID: 30615358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System of Markers Based on the Methylation of a Group of Proapoptotic Genes in Combination with MicroRNA in the Diagnosis of Breast Cancer.
    Braga EA; Burdennyy AM; Pronina IV; Filippova EA; Kazubskaya TP; Fridman MV; Khodyrev DS; Karpukhin AV; Loginov VI; Kushlinskii NE
    Bull Exp Biol Med; 2020 Jan; 168(3):366-370. PubMed ID: 31938917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
    Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
    Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
    Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
    Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
    Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C
    Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
    Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
    Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
    Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.